Last reviewed · How we verify

NCT05487313

Pain Relief After High Thoracic Eretor Spinae Block

Completed NA Last updated 30 March 2023
What this trial tests

NA trial testing Erector spinae plane block in Pain, Chronic in 82 participants. Completed in 21 March 2023.

Timeline
12 August 2022
Primary endpoint
21 March 2023
21 March 2023

Quick facts

Lead sponsorKeimyung University Dongsan Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment82
Start date12 August 2022
Primary completion21 March 2023
Estimated completion21 March 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Keimyung University Dongsan Medical Center

Who can join

Adults 20 to 80, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary endpoint of this study was to identify if the ESPB in the patients of cervical radiculopathy has the effect of pain relief. The secondary endpoint of this study was to identify the spread level in the craniocaudal direction when performed at the T2 level.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Erector spinae plane block

Trials testing the same drug.

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Keimyung University Dongsan Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05487313.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing